A Study of Once Monthly Subcutaneous Mircera in Patients With Chronic Renal Anemia Not on Dialysis

NCT00922116 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

191

Enrollment

INDUSTRY

Sponsor class

Conditions

Anemia

Interventions

DRUG: methoxy polyethylene glycol-epoetin beta [Mircera]

Sponsor

Hoffmann-La Roche